Developing, funding and conducting clinical trials in immune tolerance
An NIH-sponsored clinical trial for people with scleroderma.
BRAVOS is now enrolling study participants
The BRAVOS study may be an option for you.
A clinical trial evaluatingBrentuximab Vendotin treatment for Diffuse Cutaneous Systemic Sclerosis.
If you are between the ages of 18-70 and have been diagnosed with progressive scleroderma within the past 5 years, you may be eligible to participate. Learn more.
Find a BRAVOS clinical research center near you. Click here.